Cardioverter Defibrillator Devices Market Worth 12,520 Million USD by 2022

LONDON, Jan. 22, 2018 -- According to the new report by Meticulous Research™, the global cardioverter defibrillator devices market will reach 12,520 million USD by 2022, growing at a CAGR of 4.6% during the forecast period.

“The cardioverter defibrillator devices market is majorly driven by increasing incidence & prevalence of cardiovascular diseases with aging population, increasing sedentary lifestyle and obesity rate; and various technological advancements,” mentions Meticulous Research™.

The implantable cardioverter defibrillator accounted for the largest share, owing to “the growing demand for permanent implantable cardioverter defibrillator for the prevention of sudden cardiac arrest and related deaths in patients at high risk, increasing incidence of cardiac arrest and atrial fibrillation, growing trend of modern therapies, and increasing awareness of healthcare, especially in the developing nations.”

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3596

Asia-Pacific is the fastest growing cardioverter defibrillator devices market, primarily due to the huge population living with chronic cardiovascular diseases due to rising urbanization, growing inclination towards fast food, and changing lifestyle. In addition, improving healthcare infrastructure, rising focus of the key players to expand in emerging countries like China & India, and increasing affordability of the middle-class population are expected to indirectly support the growth of this market in Asia-Pacific.

The key players in this market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Stryker Corporation, Koninklijke Philips N.V., Cardiac Science Corporation, Zoll Medical Corporation, Nihon Kohden Corporation, Progetti Srl, Fukuda Denshi Co., and Schiller AG.

Browse in-depth report on: https://www.meticulousresearch.com/product/cardioverter-defibrillator-devices-market-2022/

Scope of the Report:
Market by Product:

• Implantable cardioverter defibrillator
  • Transvenous cardioverter defibrillator
    • Single-chamber cardioverter defibrillator
    • Dual-chamber cardioverter defibrillator
    • CRT-Ds/Biventricular cardioverter defibrillator
  • Subcutaneous cardioverter defibrillator
• External cardioverter defibrillator
  • Manual external cardioverter defibrillator
  • Automated external cardioverter defibrillator
    • Fully-automated cardioverter defibrillator
    • Semi-automated cardioverter defibrillator
  • Wearable external cardioverter defibrillator

Market by End-user:

• Hospitals
• Ambulatory surgery centre
• Others

Market by Geography:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East and Africa

Enquire before buying: https://www.meticulousresearch.com/enquire-before-buying/?cp_id=3596

Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)